147 related articles for article (PubMed ID: 31991528)
1. The relationship of serum SCUBE-1, -2 and -3 levels with clinical findings and ultrasonographic skin thickness in systemic sclerosis patients.
Gündüz İ; Batmaz İ; Bozan T; Ekinci A; Cevik R
Int J Rheum Dis; 2020 Apr; 23(4):526-531. PubMed ID: 31991528
[TBL] [Abstract][Full Text] [Related]
2. Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?
Capkin AA; Demir S; Mentese A; Bulut Ç; Ayar A
Arch Dermatol Res; 2017 Apr; 309(3):203-207. PubMed ID: 28238185
[TBL] [Abstract][Full Text] [Related]
3. The relationship between global longitudinal strain and pulmonary function tests in patients with scleroderma and normal ejection fraction and pulmonary artery pressure: a case-control study.
Hajsadeghi S; Mirshafiee S; Pazoki M; Moradians V; Mansouri P; Kianmehr N; Iranpour A
Int J Cardiovasc Imaging; 2020 May; 36(5):883-888. PubMed ID: 32060775
[TBL] [Abstract][Full Text] [Related]
4. Serum SCUBE-1 levels in patients with diabetic retinopathy.
Icel E; Icel A; Mertoglu C; Tasli NG; Karakurt Y; Ucak T; Gunay M
Int Ophthalmol; 2020 Apr; 40(4):859-865. PubMed ID: 31792853
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
[TBL] [Abstract][Full Text] [Related]
6. COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker.
Hesselstrand R; Kassner A; Heinegård D; Saxne T
Ann Rheum Dis; 2008 Sep; 67(9):1242-8. PubMed ID: 18065498
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative Assessment of Skin Thickness using High Frequency Ultrasound in Systemic Sclerosis].
Sun S; Yang YJ; Wang LY; Tang YJ; Qiu L; Su BH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):453-458. PubMed ID: 30014650
[TBL] [Abstract][Full Text] [Related]
8. Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.
Masui Y; Asano Y; Akamata K; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Rheumatol Int; 2014 Aug; 34(8):1165-70. PubMed ID: 24141536
[TBL] [Abstract][Full Text] [Related]
9. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.
Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA;
Arthritis Rheumatol; 2018 Nov; 70(11):1829-1834. PubMed ID: 29781588
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of angiogenic homeostasis in systemic sclerosis.
Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
[TBL] [Abstract][Full Text] [Related]
12. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.
Ruaro B; Soldano S; Smith V; Paolino S; Contini P; Montagna P; Pizzorni C; Casabella A; Tardito S; Sulli A; Cutolo M
Rheumatol Int; 2019 Aug; 39(8):1369-1376. PubMed ID: 31056725
[TBL] [Abstract][Full Text] [Related]
13. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis: an ultrasonographic study of skin and subcutaneous tissue in relation to clinical findings.
Sedky MM; Fawzy SM; El Baki NA; El Eishi NH; El Bohy Ael M
Skin Res Technol; 2013 Feb; 19(1):e78-84. PubMed ID: 22716275
[TBL] [Abstract][Full Text] [Related]
15. High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.
Li H; Furst DE; Jin H; Sun C; Wang X; Yang L; He J; Wang Y; Liu A
Arthritis Res Ther; 2018 Aug; 20(1):181. PubMed ID: 30115105
[TBL] [Abstract][Full Text] [Related]
16. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound assessment of skin thickness and stiffness: the correlation with histology and clinical score in systemic sclerosis.
Chen C; Cheng Y; Zhu X; Cai Y; Xue Y; Kong N; Yu Y; Xuan D; Zheng S; Yang X; Zhu Z; Zhao T; Wan W; Zou H; Liang M
Arthritis Res Ther; 2020 Aug; 22(1):197. PubMed ID: 32843083
[TBL] [Abstract][Full Text] [Related]
18. Circulating Reticulocalbin 1 and Reticulocalbin 3 in Systemic Sclerosis Patients: Results of a Case Control Study.
Bălănescu P; Lădaru A; Bălănescu E; Pompilian V; Gologanu D; Caraiola S; Băicuş C; Dan GA
Clin Lab; 2016; 62(6):1109-16. PubMed ID: 27468573
[TBL] [Abstract][Full Text] [Related]
19. Serum delta-like 4 levels: A possible association with interstitial lung disease in systemic sclerosis.
Fukui Y; Miyagawa T; Toyama S; Omatsu J; Hirabayashi M; Nakamura K; Yoshizaki A; Sato S; Asano Y
J Dermatol; 2020 Apr; 47(4):e136-e137. PubMed ID: 31984546
[No Abstract] [Full Text] [Related]
20. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis.
Yazawa N; Kikuchi K; Ihn H; Fujimoto M; Kubo M; Tamaki T; Tamaki K
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):70-5. PubMed ID: 10607322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
